TMEM88 and neoplasm: Both in vitro, in vivo and clinical studies have shown that the level of TMEM88 is significantly increased in platinum-resistant ovarian cancer xenograft nude mice, platinum-resistant ovarian cancer cells and recurrent ovarian cancer tissue, while knockdown or decrease the expression of TMEM88 can resensitize tumor cells to platinum drugs.